Winslow Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-17
| Closed | -$2K | – | 100 |
|
|
2018
Q2 | $2K | Hold |
17
| – | – | ﹤0.01% | 83 |
|
|
2018
Q1 | $2K | Hold |
17
| – | – | ﹤0.01% | 83 |
|
|
2017
Q4 | $2K | Hold |
17
| – | – | ﹤0.01% | 91 |
|
|
2017
Q3 | $2K | Hold |
17
| – | – | ﹤0.01% | 86 |
|
|
2017
Q2 | $2K | Sell |
17
-40
| -70% | -$4.71K | ﹤0.01% | 86 |
|
|
2017
Q1 | $7K | Sell |
57
-2,131,396
| -100% | -$262M | ﹤0.01% | 75 |
|
|
2016
Q4 | $261M | Buy |
2,131,453
+2,131,134
| +668,067% | +$261M | 1.2% | 34 |
|
|
2016
Q3 | $39K | Sell |
319
-26
| -8% | -$3.18K | ﹤0.01% | 142 |
|
|
2016
Q2 | $40K | Sell |
345
-3,134,207
| -100% | -$363M | ﹤0.01% | 136 |
|
|
2016
Q1 | $436M | Buy |
3,134,552
+70,421
| +2% | +$9.8M | 1.71% | 20 |
|
|
2015
Q4 | $584M | Sell |
3,064,131
-147,025
| -5% | -$28M | 2.09% | 15 |
|
|
2015
Q3 | $502M | Buy |
3,211,156
+321,355
| +11% | +$50.3M | 1.83% | 18 |
|
|
2015
Q2 | $522M | Buy |
2,889,801
+916,750
| +46% | +$166M | 1.74% | 19 |
|
|
2015
Q1 | $342M | Sell |
1,973,051
-1,375,951
| -41% | -$238M | 1.05% | 47 |
|
|
2014
Q4 | $620M | Sell |
3,349,002
-18,084
| -0.5% | -$3.35M | 1.91% | 15 |
|
|
2014
Q3 | $558M | Buy |
3,367,086
+493,654
| +17% | +$81.9M | 1.71% | 20 |
|
|
2014
Q2 | $449M | Buy |
2,873,432
+44,057
| +2% | +$6.88M | 1.37% | 26 |
|
|
2014
Q1 | $430M | Sell |
2,829,375
-568,578
| -17% | -$86.5M | 1.35% | 28 |
|
|
2013
Q4 | $452M | Buy |
3,397,953
+631,826
| +23% | +$84M | 1.33% | 30 |
|
|
2013
Q3 | $321M | Sell |
2,766,127
-1,419,963
| -34% | -$165M | 1.04% | 47 |
|
|
2013
Q2 | $386M | Buy |
+4,186,090
| New | +$386M | 1.26% | 36 |
|